You are required to be logged in to access the full website
Click here if you have forgotten your username or password
18 November 2026 - Biopharmaceutical company Bristol Myers Squibb (NYSE: BMY) on Wednesday reported preliminary results from two Phase 3 studies evaluating investigational drug KarXT (xanomeline and trospium chloride) for psychosis associated with Al...
18 November 2026 - Norwegian bladder cancer diagnostics company Photocure ASA (OSE: PHO) said on Wednesday that it has signed an agreement with pharmaceutical services provider Clinigen to supply Hexvix through a Named Patient Program (NPP) in more t...
18 November 2026 - US biopharmaceutical company Pfizer Inc (NYSE:PFE) announced on Wednesday that it has entered into an exclusive licensing agreement with biotechnology company Starna Therapeutics to develop and commercialise three preclinical in vi...
18 November 2026 - DDL, a third-party testing laboratory specialising in medical device and pharmaceutical packaging, combination products, and materials testing, announced on Tuesday that it has launched a new Pharmaceutical Consulting Services prog...
18 November 2026 - Ichnos Glenmark Innovation Inc (IGI), a clinical-stage biotechnology company focused on developing Multispecific therapeutics in oncology, announced on Tuesday the submission of an Investigational New Drug (IND) application to the ...
M2 Pharma brings you breaking news and information on the
global pharmaceuticals industry, helping you to stay one step ahead of the competition.
Click here to subscribe
Click here to subscribe